Home/Filings/4/0001104659-20-048727
4//SEC Filing

Semerjian Harout 4

Accession 0001104659-20-048727

CIK 0000722830other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 4:41 PM ET

Size

7.5 KB

Accession

0001104659-20-048727

Insider Transaction Report

Form 4
Period: 2020-04-16
Semerjian Harout
DirectorPresident and CEO
Transactions
  • Award

    Common Stock, $0.01 par value per share

    2020-04-16+50,07550,075 total
  • Award

    Stock option (right to buy)

    2020-04-16+252,602252,602 total
    Exercise: $19.97Exp: 2027-04-16Common Stock, Par value $0.01 per share (252,602 underlying)
Footnotes (3)
  • [F1]Harout Semerjian was granted restricted stock units pursuant to the Issuer's 2014 Long-Term Incentive Plan (the "Plan"). 1/2 of the restricted stock units vest on each of the first and second anniversary of the date of grant, subject to Mr. Semerjian's continued service as the Company's President and Chief Executive Officer.
  • [F2]Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock.
  • [F3]Mr. Semerjian was granted stock options pursuant to the Plan. The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001809747

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:41 PM ET
Size
7.5 KB